| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000010433 |
| Receipt No. | R000012199 |
| Official scientific title of the study | effect of rebamipide on dry eye syndrome related to chronic graft versus host disease a randomized parallel group trial |
| Date of disclosure of the study information | 2013/04/06 |
| Last modified on | 2016/08/01 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | effect of rebamipide on dry eye syndrome related to chronic graft versus host disease
a randomized parallel group trial |
|
| Title of the study (Brief title) | effect of rebamipide on gvhd related dry eye | |
| Region |
|
|
| Condition | ||
| Condition | To investigate the treatment efficacy of rebamipide on chronic GVHD dry eye | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the treatment efficacy of rebamipide on chronic GVHD dry eye |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | anterior ocular segment remark
corneal sensitivity schrmer test tear film breakup time fluorescein staining lisamine green staining subjective symptom oxidative stress marker in tear film |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Rebamipide ophthalmic suspension, vitamin A ophthalmic solution, or/and sodium hyaluronate ophthalmic solution | |
| Interventions/Control_2 | Artificial tears, vitamin A ophthalmic solution, or/and sodium hyaluronate ophthalmic solution | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 newly diagnosed dry eye patients after hematopoietic stem cell transplantation
2 dry eye severity level 1 2 3 dews 2007 |
|||
| Key exclusion criteria | 1 dry eye severity level 4 dews 2007
2 patients having a concern of becoming severe dry eye because of having gvhd in other organs and so on 3 patients with sjogrens syndrome, ocular pemphigoid, and Stevenes-Johnson symdrome 4 patients with a history of ophthalmic surgery 5 patients wearing contact lens 6 patients who will be applied radiation treatment during the study 7 patients dosed cevimeline hydrochloride hydrate and or pilocarpine eye drop or oral drug |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yoko Ogawa |
| Organization | Keio University School of Medicine |
| Division name | Department of Ophthalmology |
| Address | Shinanomachi 35, Shinjuku-ku. Tokyo 160-8582 |
| TEL | 03-5363-3972 |
| yoko@z7.keio.jp | |
| Public contact | |
| Name of contact person | Yoko Ogawa |
| Organization | Keio University School of Medicine |
| Division name | Department of Ophthalmology |
| Address | 35 Shinanomachi Shinjukuku Tokyo, Japan |
| TEL | 03-5363-3972 |
| Homepage URL | |
| yoko@z7.keio.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012199 |